Trials / Completed
CompletedNCT05599399
Impact of Gum Acacia on Chronic Kidney Disease Patients
Impact of Gum Acacia on Gut-microbiota Derived Metabolites in Chronic Kidney Disease Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the impact of gum acacia on serum levels of protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate).In addition to the evaluation of its effect on metabolic profile and disease progression in chronic kidney disease patients.
Detailed description
1. Ethical committee approval has been obtained from Ethics committee of Faculty of Medicine, Alexandria University. 2. All participants should agree to take part in this clinical study and will provide informed consent. 3. Eighty chronic kidney disease patients,will be recruited from the Kidney and Urology Center (KUC) and Alexandria main university hospital (AMUH). The 80 participants will be randomly assigned into 2 arms. Control arm (n=40): will be treated with standard treatment without any herbal intervention. Intervention arm (n=40): will be treated with standard treatment in addition to gum acacia sachets. Each sachet contains 25 g of gum acacia powder to be taken on daily-basis for 3 months. 4. All patients will be submitted to : * Full patient history and clinical examination. * Blood withdrawal in order to conduct lab work. 5. Patients demographic data will be recorded with respect to age, weight and other co-morbidities. 6. Statistical tests appropriate to the study design will be conducted to evaluate the significance of the results. 7. Results, conclusion, discussion and recommendations will be given.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Gum acacia | 25 grams of gum acacia powder is administered on daily-basis |
Timeline
- Start date
- 2022-07-18
- Primary completion
- 2023-01-17
- Completion
- 2023-04-28
- First posted
- 2022-10-31
- Last updated
- 2023-06-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05599399. Inclusion in this directory is not an endorsement.